<DOC>
	<DOCNO>NCT01818960</DOCNO>
	<brief_summary>Revascularization strategy ST elevation myocardial infarction ( STEMI ) study ( ASSIST-CMR ) compare effect two revascularization strategy [ sit multivessel primary PCI ( SS-PCI ) culprit vessel primary PCI ( IRA-PCI ) ] myocardial infarct size ( MIS ) determine cardiac magnetic resonance ( CMR ) image patient present STEMI multivessel disease ( MVD ) .</brief_summary>
	<brief_title>Revascularization Strategies STEMI ; The CMR Endpoint Study</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>High risk ST elevation myocardial infarction evidence : ≥2 mm ST elevation 2 anterior lateral lead ; ≥2 mm ST elevation 2 inferior couple ST depression 2 contiguous anterior lead total ST deviation ≥8 mm ; New leave bundle branch block least 1 mm concordant ST elevation . Multivessel CAD evidence ≥1 significant ( ≥70 % visual assessment FFR &lt; 0.80 5070 % stenosis ) stenosis nonIRA . Successful IRAPCI &lt; 10 % residual angiographic stenosis TIMI III flow . Written informed consent . Age ≤ 18 year . Prior coronary artery bypass graft ( CABG ) surgery . Administration thrombolytic therapy . NonIRA stenosis chronic total occlusion locate leave main artery . Hemodynamic instability evidence BP &lt; 90 mmHg , Killip class ≥2 , need inotropes/vasopressors . Known renal insufficiency ( estimate GFR &lt; 50ml/min ) . Contraindication CMR .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Stent , Myocardial Infarction , Coronary Intervention</keyword>
</DOC>